Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Sep 11.

Published in final edited form as: Vaccine. 2012 Apr 3;30(26):3937–3943. doi: 10.1016/j.vaccine.2012.03.071

Table 2.

Summary of associations between host factors and serologic response by influenza subtype

	H1N1	H3N2	B
Seroconversion	28%	66%	31%
VES-13	+	NS	NS
BMI ≥ 30 kg/m²	NS	+	NS
Age	NS	NS	NS
Gender	NS	NS	NS
Comorbidities	NS	NS	NS
Seroprotection	44%	78%	95%
VES-13	NS	NS	ND
BMI ≥ 30 kg/m²	NS	NS	ND
Age	NS	NS	ND
Gender	NS	NS	ND
Comorbidities	NS	NS	ND
Post-vaccination HAI titer
VES-13	+	NS	NS
BMI ≥ 30 kg/m²	NS	+	NS
Age	NS	NS	−
Gender	NS	−	NS
Comorbidities	NS	NS	NS

NS not significant

ND not done due to high proportion of seroprotected subjects

+ direct association